AMIVF Statistics
Total Valuation
AMIVF has a market cap or net worth of 370.04 million.
Market Cap | 370.04M |
Enterprise Value | n/a |
Important Dates
The next estimated earnings date is Wednesday, May 14, 2025.
Earnings Date | May 14, 2025 |
Ex-Dividend Date | May 30, 2025 |
Share Statistics
Current Share Class | 47.41M |
Shares Outstanding | n/a |
Shares Change (YoY) | +0.76% |
Shares Change (QoQ) | +4.72% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 45.11M |
Valuation Ratios
The trailing PE ratio is 11.13 and the forward PE ratio is 10.59.
PE Ratio | 11.13 |
Forward PE | 10.59 |
PS Ratio | 9.15 |
PB Ratio | 1.03 |
P/TBV Ratio | 1.03 |
P/FCF Ratio | n/a |
P/OCF Ratio | 7.82 |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 43.41, with a Debt / Equity ratio of 0.63.
Current Ratio | 43.41 |
Quick Ratio | 43.41 |
Debt / Equity | 0.63 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 9.58%.
Return on Equity (ROE) | 9.58% |
Return on Assets (ROA) | 5.49% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | 40.46M |
Profits Per Employee | 33.26M |
Employee Count | 1 |
Asset Turnover | 0.07 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -4.39% in the last 52 weeks. The beta is 0.96, so AMIVF's price volatility has been similar to the market average.
Beta (5Y) | 0.96 |
52-Week Price Change | -4.39% |
50-Day Moving Average | 7.53 |
200-Day Moving Average | 7.90 |
Relative Strength Index (RSI) | 66.65 |
Average Volume (20 Days) | 1,074 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, AMIVF had revenue of 40.46 million and earned 33.26 million in profits. Earnings per share was 0.73.
Revenue | 40.46M |
Gross Profit | 34.51M |
Operating Income | 33.29M |
Pretax Income | 33.26M |
Net Income | 33.26M |
EBITDA | n/a |
EBIT | n/a |
Earnings Per Share (EPS) | 0.73 |
Balance Sheet
Cash & Cash Equivalents | n/a |
Total Debt | 227.57M |
Net Cash | -227.57M |
Net Cash Per Share | n/a |
Equity (Book Value) | 359.30M |
Book Value Per Share | 7.62 |
Working Capital | 586.11M |
Cash Flow
Operating Cash Flow | 47.35M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 85.30%, with operating and profit margins of 82.28% and 82.20%.
Gross Margin | 85.30% |
Operating Margin | 82.28% |
Pretax Margin | 82.20% |
Profit Margin | 82.20% |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.76, which amounts to a dividend yield of 9.79%.
Dividend Per Share | 0.76 |
Dividend Yield | 9.79% |
Dividend Growth (YoY) | -13.04% |
Years of Dividend Growth | n/a |
Payout Ratio | 81.47% |
Buyback Yield | -0.76% |
Shareholder Yield | 9.03% |
Earnings Yield | 8.99% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |